Health & Wellbeing

31 May 2025

New Alzheimer’s treatment

Developed by Eli Lilly, Kisunla is the first medicine approved in Australia that targets the underlying cause of Alzheimer’s by clearing the amyloid plaques that disrupt brain function. It is the first new Alzheimer’s treatment registered in Australi...

29 May 2025

Young Aussies still in aged care

Head of Policy, Communications and Systems Change at the Summer Foundation, Jessica Walker, said the data showed the downward trend in the number of younger people with disability entering residential aged care had slowed considerably in recent quart...

26 May 2025

Drug trial targets stubborn cholesterol

The clinical trial ‘BROADWAY’ tested a once-daily oral medication called Obicetrapib, and found it significantly lowered both LDL cholesterol and lipoprotein(a), two key contributors to cardiovascular disease. The BROADWAY phase 3 trial results were ...